The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

Share Price Information for Surface Transforms (SCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.175
Bid: 1.15
Ask: 1.20
Change: 0.00 (0.00%)
Spread: 0.05 (4.348%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.175
SCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects

25 Oct 2019 12:56

Hardman & Co Research Hardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects 25-Oct-2019 / 12:56 GMT/BST


Hardman & Co Research: Recent major contract wins transform prospects

ST's results, announced 9 September, were in line with expectations. Since then, ST has secured a further £0.4m revenue, prompting us to upgrade FY19 PBT estimates by £0.25m. Historical results do not reflect a series of substantial new contracts won, post May 2019 year-end, which have transformed the company. It now has multi-year, multi-million, recurring income contracts from Europeanbased global OEMs. Revenue from one commences October 2021, with start of production (SOP) for the other towards the end of calendar 2021. These will support EBITDA-positive (post-tax credit) for 2020 and profitability in 2022. Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/recent-major-contract-wins-transform-prospects/

 

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contacts:

Mike Foster 

+44 20 20 7451 7050

 

mf@hardmanandco.com

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

897473 25-Oct-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Sep 20217:00 amRNSContract Award from OEM 5
17th Aug 20217:00 amRNSContract award from OEM 10 and notice of results
8th Jul 20217:00 amRNSTrading and operations update
5th Jul 20213:00 pmRNSExercise of options
9th Jun 20218:45 amEQSHardman & Co Research : Hardman Talks Video| Surface Transforms Management Presentation
2nd Jun 20219:43 amRNSResult of Annual General Meeting
28th May 202111:18 amRNSExercise of Options
27th May 202111:51 amRNSMeet the Directors and Q&A
25th May 20217:00 amRNSDirector Dealing
20th May 20219:30 amEQSHardman & Co Research : Hardman Talks Video Event | Surface Transforms - Q&A with the Board
13th May 20217:00 amRNSDirector Dealing
4th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
22nd Apr 20215:38 pmRNSPDMR Dealing
22nd Apr 20215:33 pmRNSDirector Dealing
19th Apr 20215:46 pmRNSExercise of Options
13th Apr 20217:00 amRNSDirector Dealing
12th Apr 20217:00 amRNSPreliminary Results and Notice of AGM
24th Mar 20217:00 amRNS£1 million loan agreement with LCRCA
15th Mar 20213:55 pmEQSHardman & Co Research: Surface Transforms (SCE): Everything has come together
15th Mar 20217:00 amRNSRetirement of NED & update on preliminary results
5th Mar 20217:00 amRNSAppointment of non-executive directors
24th Feb 20217:00 amRNSGrant of Options
18th Feb 20213:15 pmRNSCorrection: Exercise of Options
18th Feb 20218:54 amRNSExercise of Options
15th Feb 20217:00 amRNSPDMR Dealing
12th Feb 202111:31 amRNSDirector Dealing
11th Feb 20212:39 pmRNSHolding(s) in Company
10th Feb 202112:37 pmRNSHolding(s) in Company
10th Feb 202111:14 amRNSExercise of Options
10th Feb 202111:10 amRNSHolding(s) in Company
8th Feb 202110:35 amRNSResult of General Meeting
8th Feb 20217:00 amRNSResult of Over-Subscribed Open Offer
2nd Feb 20212:30 pmEQSHardman & Co Research : Hardman Talks video release - Surface Transforms management discuss fundraising
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSOnline investor presentation
20th Jan 20218:09 amRNSResult of Placing and Subscription, & Notice of GM
19th Jan 20215:35 pmRNSProposed Placing, Subscription and Open Offer
8th Jan 20215:13 pmRNSReplacement announcement - director dealings
5th Jan 20217:00 amRNSTrading, OEM Pipeline & Operations Update
30th Nov 20209:48 amRNSDirector Dealing
19th Nov 20205:59 pmRNSExercise of Options
22nd Oct 20204:44 pmRNSDirector Dealing
21st Oct 20207:00 amRNSGrant of Options
6th Oct 20203:37 pmRNSPDMR dealing
6th Oct 20203:26 pmRNSDirector dealing
6th Oct 20203:00 pmRNSDirector Dealing
28th Sep 20207:00 amRNSHalf-year results for 6 months ended 30 June 2020
15th Sep 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): A whole new level of contract winning
15th Sep 20208:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.